Your browser doesn't support javascript.
loading
α-Synuclein Aggregation Inhibitory Prunolides and a Dibrominated ß-Carboline Sulfamate from the Ascidian Synoicum prunum.
Holland, Darren C; Prebble, Dale W; Er, Safak; Hayton, Joshua B; Robertson, Luke P; Avery, Vicky M; Domanskyi, Andrii; Kiefel, Milton J; Hooper, John N A; Carroll, Anthony R.
Afiliação
  • Holland DC; School of Environment and Science, Griffith University, Southport, Queensland 4222, Australia.
  • Prebble DW; Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia.
  • Er S; School of Environment and Science, Griffith University, Southport, Queensland 4222, Australia.
  • Hayton JB; Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia.
  • Robertson LP; HiLIFE, Institute of Biotechnology, University of Helsinki, Helsinki 00014, Finland.
  • Avery VM; Faculty of Pharmacy, University of Helsinki, Helsinki 00014, Finland.
  • Domanskyi A; School of Environment and Science, Griffith University, Southport, Queensland 4222, Australia.
  • Kiefel MJ; Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia.
  • Hooper JNA; School of Environment and Science, Griffith University, Southport, Queensland 4222, Australia.
  • Carroll AR; Griffith Institute for Drug Discovery, Griffith University, Nathan, Queensland 4111, Australia.
J Nat Prod ; 85(2): 441-452, 2022 02 25.
Article em En | MEDLINE | ID: mdl-35050597
ABSTRACT
Seven new polyaromatic bis-spiroketal-containing butenolides, the prunolides D-I (4-9) and cis-prunolide C (10), a new dibrominated ß-carboline sulfamate named pityriacitrin C (11), alongside the known prunolides A-C (1-3) were isolated from the Australian colonial ascidian Synoicum prunum. The prunolides D-G (4-7) represent the first asymmetrically brominated prunolides, while cis-prunolide C (10) is the first reported with a cis-configuration about the prunolide's bis-spiroketal core. The prunolides displayed binding activities with the Parkinson's disease-implicated amyloid protein α-synuclein in a mass spectrometry binding assay, while the prunolides (1-5 and 10) were found to significantly inhibit the aggregation (>89.0%) of α-synuclein in a ThT amyloid dye assay. The prunolides A-C (1-3) were also tested for inhibition of pSyn aggregate formation in a primary embryonic mouse midbrain dopamine neuron model with prunolide B (2) displaying statistically significant inhibitory activity at 0.5 µM. The antiplasmodial and antibacterial activities of the isolates were also examined with prunolide C (3) displaying only weak activity against the 3D7 parasite strain of Plasmodium falciparum. Our findings reported herein suggest that the prunolides could provide a novel scaffold for the exploration of future therapeutics aimed at inhibiting amyloid protein aggregation and the treatment of numerous neurodegenerative diseases.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Limite: Animals País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article